{"name": "Juvaris BioTherapeutics",
 "permalink": "juvaris-biotherapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/juvaris-biotherapeutics",
 "homepage_url": "http://www.juvaris.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@juvaris.com",
 "phone_number": "650-259-1800",
 "description": "Cancer Vaccine Research",
 "created_at": "Fri Jul 24 03:39:13 UTC 2009",
 "updated_at": "Tue Aug 03 00:26:38 UTC 2010",
 "overview": "\u003Cp\u003EJuvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. \u003C/p\u003E\n\n\u003Cp\u003EThe Company\u0026#8217;s platform technology induces profound immunostimulation via cationic lipid-DNA (non-coding) complexes (CLDC). The Company\u0026#8217;s lead product candidate, JVRS-100, stimulates adaptive and innate immune responses at levels many fold higher than other drugs in its class. JVRS-100 is in clinical development as a vaccine adjuvant and an immunotherapeutic. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       66],
      "assets/images/resized/0005/4084/54084v1-max-150x150.jpg"],
     [[214,
       95],
      "assets/images/resized/0005/4084/54084v1-max-250x250.jpg"],
     [[214,
       95],
      "assets/images/resized/0005/4084/54084v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$54M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://deals.venturebeat.com/2007/01/05/cancer-vaccine-developer-juvaris-raises-753m-led-by-kleiner-perkins/",
    "source_description": "Cancer vaccine developer Juvaris raises $7.53M, led by Kleiner Perkins",
    "raised_amount": 7530000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 1,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "http://deals.venturebeat.com/2007/08/02/vaccine-maker-juvaris-bio-gets-9m-government-grant/",
    "source_description": "Vaccine maker Juvaris Bio gets $9M government grant",
    "raised_amount": 9000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 8,
    "funded_day": 2,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2010/01/uvaris-biotherapeutics-completes-second.html",
    "source_description": "Juvaris BioTherapeutics Completes Second Close on $25M Series B Financing",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 27,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://onbiovc.com/juvaris-biotherapeutics-inc-series-b-125m-2/",
    "source_description": "Juvaris BioTherapeutics, Inc.: Series B $12.5M",
    "raised_amount": 12500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "866 Malcolm Road",
    "address2": "Suite 100",
    "zip_code": "94010 ",
    "city": "Burlingame",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.600152,
    "longitude": -122.373135}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        85],
       "assets/images/resized/0005/4085/54085v1-max-150x150.jpg"],
      [[250,
        143],
       "assets/images/resized/0005/4085/54085v1-max-250x250.jpg"],
      [[450,
        257],
       "assets/images/resized/0005/4085/54085v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}